Tag Archive for financial results

Natura Completes Corporate Streamlining, Reports R$ 6.2 Billion Revenues in Q4 2025

SÃO PAULO, Brazil – Natura (B3: NATU3) today presented its fourth-quarter and full-year 2025 results. In a year marked by the final steps of its corporate streamlining process, the Company sharpened its focus on Latin America and achieved strong profitability growth. The recurring EBITDA margin in the region reached 16.1% in 4Q-25. For the full year 2025, recurring profitability was 14.6%, an increase of 130 basis points compared to the previous year.
Highlights

Divestments of Avon International and Avon Russia mark the conclusion of the corporate streamlining process
Completion of the Natura–Avon brand unification (Wave 2) in Mexico and Argentina brings transformation costs to a close, coming in below 2024 levels
Annual recurring EBITDA margin reaches 14.6% (+130 bps increase), driven by the 16.1% growth in 4Q-25 in Latin America
Solid cash generation, despite revenue challenges, leads to leverage within the optimal range by the end of 2025
Continuing operations delivering net income of nearly R$ 1 billion

The completion of the sales of Avon International and Avon Russia marked the final milestone in Natura’s corporate streamlining and capital structure reorganization. The Company ended the year with financial leverage at 1.31x, within the optimal capital structure range.
With the integration of Mexico and Argentina, the operational unification of

Read more...

Nature’s Sunshine Reports Strong Fourth Quarter and Full Year 2025 Financial Results

LEHI, Utah – Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (“Nature’s Sunshine” and/or the “Company”), a global leader in manufacturing and marketing high-quality herbal and nutritional supplements, reported financial results for the fourth quarter and full year ended December 31, 2025.
Summary of Q4 and Full Year 2025 Results
Q4 2025 FINANCIAL SUMMARY VS. SAME YEAR-AGO QUARTER

Net sales increased 4.7% to $123.8 million compared to $118.2 million (up 3.8% in constant currency).
GAAP net income attributable to common shareholders of $4.1 million, or $0.23 per diluted share, compared to net loss of $0.3 million, or $(0.02) per diluted share.
Adjusted EBITDA up 16% to $11.9 million compared to $10.3 million.

FULL YEAR 2025 FINANCIAL SUMMARY VS. 2024

Net sales increased 5.7% to $480.1 million compared to $454.4 million (up 5.3% in constant currency).
GAAP net income attributable to common shareholders of $19.5 million, or $1.06 per diluted share, compared to $7.7 million, or $0.40 per diluted share.
Adjusted EBITDA up 21.7% to $49.4 million compared to $40.5 million.

Click to read the detailed report on Q4 and FY 2025 for Nature’s Sunshine
Management Commentary

“We finished a record year in sales and delivered our second‑best quarter ever and our largest Q4 on record, with sales and adjusted EBITDA up 5% and 16%, respectively,”

Read more...

LR Health & Beauty SE Reports FY2025 Results, Plans Bond Restructuring

LR Health & Beauty SE: Preliminary Results For Financial Year 2025, Target Equity Contribution, and Targeted Restructuring of the 2024/2028 Bonds. 
Ahlen, Germany – Based on the preliminary financial results for the financial year 2025, the Management Board of LR Health & Beauty SE (the “Company”) now expects an EBITDA* reported of around EUR 16 million for the financial year 2025 (previously expected to be between EUR 17.0 million and EUR 20.0 million). At the same time, the Management Board of the Company expects sales (revenue from goods sold) of around EUR 277 million for the full year 2025 (previously expected to be between EUR 276 million and EUR 281 million).
Also today, EY-Parthenon announced the completion of a draft IDW S 6 restructuring opinion in respect of the Company. Pursuant to the analysis set out in that draft restructuring opinion, the Company will for the financial year 2028 achieve an EBITDA* of EUR 27.3 million and sales of EUR 281.5 million in the sensitivity case, and an EBITDA* of EUR 31.4 million as well as sales of EUR 284.7 million in the management case.

Against this background, the Company decided today to enter into discussions with its shareholder and with the bondholders of the

Read more...

Zinzino Preliminary Sales Report 2025

Zinzino group revenue increased 46% in Q4 and total revenue for the full year 2025 increased 51%, compared with the previous year.
The revenue in December for Zinzino‘s sales markets increased by 35% and amounted to SEK 334.4 (246.9) million. Faun Pharma’s external sales decreased and amounted to SEK 2.9 (5.8) million. Overall, the Group increased revenues by 33% to SEK 337.3 (252.7) million compared with the previous year.
Revenue in Zinzino’s sales markets increased by 50% in the fourth quarter of 2025 compared with the same period last year and amounted to SEK 1,032.3 (690.3) million. Total revenues in the Group increased by 46% in the fourth quarter and amounted to SEK 1,042.4 (713.5) million.
Accumulated revenue for January – December 2025 increased by 51% to SEK 3,344.5 (2,207.8) million.
Revenues were distributed as follows:

Regions, mSEK
25-Dec
24-Dec
Change
Q4 2025
Q4 2024
Change
YTD 2025
YTD 2024
Change

The Nordics
31.4
29.6
6%
98.4
88.0
12%
332.5
302.0
10%

Central Europe
102.9
78.1
32%
337.9
202.3
67%
995.4
596.7
67%

East Europe
36.3
34.5
5%
122.0
120.6
1%
398.0
400.4
-1%

South & West Europe
53.7
49.7
8%
167.8
131.9
27%
565.8
396.4
43%

The Baltics
18.0
12.0
50%
48.3
38.2
26%
133.5
107.6
24%

North America
52.0
21.1
146%
163.8
66.3
147%
545.7
200.5
172%

Asia-Pacific
37.4
20.2
85%
86.2
37.1
132%
299.4
84.6
254%

Africa
2.7
1.7
59%
7.8
5.9
32%
23.8
16.8
42%

Zinzino
334.4
246.9
35%
1,032.3
690.3
50%
3,294.1
2,105.0
56%

Faun Pharma
2.9
5.8
-50%
10.1
23.2
-57%
50.4
102.8
-51%

Zinzino Group
337.3
252.7
33%
1,042.4
713.5
46%
3,344.5
2,207.8
51%

Countries in regions:

The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
Central Europe: Austria, Germany, Switzerland
East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
The Baltics: Estonia, Latvia, Lithuania
North America: Canada, USA, Mexico
Asia-Pacific: Australia, New Zealand, Hong

Read more...

Mannatech Reports Financial Results for Third Quarter 2025

Mannatech Announces Q3 2025 Results Highlighting Margin Improvements and Stronger Profitability
Mannatech, Incorporated has released its financial results for the third quarter of 2025, reporting notable gains in margins and profitability, with Asia-Pacific continuing to be the strongest region for the company. Gross profit as a percentage of net sales rose to 76.4%, supported by pricing adjustments, efficient inventory management, and the timing of promotional activities.
Operational performance also strengthened. Income from operations increased to $2.0 million, more than double the prior-year period, while net income reached $1.9 million, or $1.01 per diluted share, compared to a loss in Q3 2024.
Asia-Pacific remained the company’s leading region, generating $18.8 million, or more than 64% of total quarterly revenue, followed by $7.9 million from the Americas.
Mannatech reported 119,000 active associate and preferred customer positions, with Asia-Pacific continuing to be the most consistent region for ongoing activity.
Net sales for the quarter totaled $29.2 million, compared to $31.7 million in the same period of 2024 — a change the company attributes to slowing demand in certain regions.
Importantly, the company noted that Q3 sales exceeded the first two quarters of 2025, indicating improved momentum as the year progressed.
Mannatech closed the quarter with $7.1 million in cash and cash

Read more...

eXp World Holdings Reports Revenue Increased 7% in Q3

eXp World Holdings, Inc. (Nasdaq: EXPI), or the “Company”, the holding company for eXp Realty®, FrameVR.io and SUCCESS® Enterprises, today announced financial results for the third quarter ended September 30, 2025.

“Our third quarter results underscore the strength of eXp’s model and the power of our agents,”

said Leo Pareja, CEO of eXp Realty.

“Continued momentum in agent growth, productivity and retention are driving higher revenue, profitability and overall performance. Our agent-first culture, combined with ongoing innovation across the eXp platform, continues to attract and empower top agents and teams around the world. As we scale, our focus remains on delivering even greater value to our agents — because when they thrive, eXp thrives.”

Glenn Sanford, Founder, Chairman and CEO of eXp World Holdings, shared:

“eXp continues to solidify its position as the platform for the future of real estate. 

“Now more than ever, eXp is the place for agents to be as the industry evolves globally and agents seek a platform that provides not just flexibility, but the resources to thrive — from SUCCESS® coaching and elite training programs to mentorship, community, and a compelling value stack that supports both business and personal growth. Our third quarter results are a reflection of eXp’s continued

Read more...

Zinzino Preliminary Sales Report: 48% Increase in Q3

Zinzino group revenue increased 48% in Q3, compared with the previous year.
The revenue in September 2025 for Zinzino‘s sales markets increased by 53 % and amounted to SEK 273.5 (178.7) million. Faun Pharma’s external sales decreased and amounted to SEK 3.7 (5.8) million. Overall, the Group increased revenues by 50% to SEK 277.2 (184..5) million compared with the previous year.
Revenue in Zinzino‘s sales markets increased by 54 % in the third quarter of 2025 compared with the same period last year and amounted to SEK 777.3 (504.4) million. Total revenues in the Group increased by 48% in the third quarter and amounted to SEK 786.7 (532.8) million.
Accumulated revenue for January – September 2025 increased by 54% to SEK 2,304.9 (1,494.3) million.
Revenues were distributed as follows:

Regions, mSEK
25-Sep
24-Sep
Change
Q3 2025
Q3 2024
Change
YTD 2025
YTD 2024
Change

The Nordics
26.5
25.4
4%
79.6
72.5
10%
235.1
214.0
10%

Central Europe
93.8
48.7
93%
242.8
138.6
75%
657.9
394.4
67%

East Europe
29.4
28.3
4%
89.7
88.3
2%
276.2
279.9
-1%

South & West Europe
50.1
38.0
32%
137.2
104.2
32%
399.2
264.5
51%

The Baltics
8.9
7.2
24%
28.6
21.9
31%
85.3
69.4
23%

North America
41.3
20.3
103%
129.8
52.6
147%
382.1
134.0
185%

Asia-Pacific
21.6
9.6
125%
63.7
22.3
186%
212.7
47.5
348%

Africa
1.9
1.2
58%
5.8
4.0
46%
16.0
10.9
47%

Zinzino
273.5
178.7
53%
777.3
504.4
54%
2264.5
1414.6
60%

Faun Pharma
3.7
5.8
-36%
9.4
28.4
-67%
40.4
79.7
-49%

Zinzino Group
277.2
184.5
50%
786.7
532.8
48%
2304.9
1494.3
54%

Countries in regions:
– The Nordics: Denmark, Faroe Island, Finland, Iceland, Norway, Sweden
– Central Europe: Austria, Germany, Switzerland
– East Europe: Czech Republic, Slovakia, Hungary, Poland, Romania
– South & West Europe: Cyprus, France, Greece, Italy, Luxembourg, Malta, Netherlands, Slovenia, Spain, United Kingdom, Belgium, Ireland, Serbia, Turkey, Canary Islands
– The Baltics: Estonia, Latvia, Lithuania
– North America: Canada, USA, Mexico
– Asia-Pacific: Australia, New Zealand, Hong

Read more...

Primerica Reports 9% Increase in Revenues, Strong First Quarter 2025

Primerica, Inc. (NYSE: PRI), a leading provider of financial services to middle-income families in North America, has announced financial results for the first quarter ended March 31, 2025.
Total revenues reached $804.8 million, a 9% increase compared to the first quarter of 2024. Net income was $169.1 million, up 14% year-over-year. Earnings per diluted share were $5.05, an increase of 19% compared to the prior year period.
Adjusted results were similarly strong:

Adjusted operating revenues: $803.6 million, up 9%

Adjusted net operating income: $168.1 million, up 14%

Diluted adjusted operating EPS: $5.02, up 20%

Glenn Williams, CEO of Primerica said.

“Our results this quarter highlight the strength and consistency of our business, Momentum in our Investment and Savings Products Segment, along with steady performance in our Term Life business, contributed to strong financial results this quarter.”

Segment Highlights
Term Life Insurance

Revenue: $457.8 million (↑ 4%)

Policies Issued: 86,415

Productivity: 0.19 policies/month per life-licensed rep

Operating margin: 22.1%

Investment and Savings Products (ISP)

Product Sales: $3.6 billion (↑ 28%)

Net Inflows: $839 million

Client Asset Value: $110 billion (↑ 6%)

Segment Revenues: $290.8 million (↑ 19%)

Pre-tax income: $81.3 million (↑ 24%)

Corporate and Other Distributed Products

Adjusted operating loss: $8.0 million (vs. $11.7M loss in Q1 2024)

Distribution Growth

New Recruits: 100,867

Newly Licensed Representatives: 12,339

Total Life-Licensed Sales Force: 152,167 (↑ 7% YoY)

Capital

Read more...

Mannatech Q1 Sales $40.6 Million

 
Mannatech, Incorporated (NASDAQ: MTEX), a global health and wellness company committed to transforming lives to make a better world, today announced financial results for its first quarter of 2017.
First quarter net sales for 2017 were $40.6 million, a decrease of $0.1 million, or 0.2% as compared to $40.7 million in the first quarter of 2016. Income (loss) from operations was $(2.0) million for the first quarter 2017, as compared to $0.5 million in the same period in 2016.
Net income (loss) was $(1.2) million, or $(0.46) per diluted share, for the first quarter 2016, as compared to $0.6 million, or $0.21 per diluted share, for the first quarter 2016.
For the three months ended March 31, 2017, Mannatech’s operations outside of the Americas accounted for approximately 61.8% of Mannatech’s consolidated net sales.
First quarter 2017 Asia/Pacific net sales increased by $0.5 million, or 2.3%, to $21.9 million, as compared to $21.4 million for the same period in 2016. This increase was primarily due to a 7.9% increase in the number of active independent associates and members partially offset by a 5.1% decrease in revenue per active independent associate and member.
During the three months ended March 31, 2017, the loyalty program increased sales by

Read more...

ForeverGreen – FgXpress Q2 2016 Revenue Down 32.8% To $10.8 Million

 
ForeverGreen Worldwide Corporation, a leading direct marketing company and provider of health-centered products, announced today financial results for the second quarter ended June 30, 2016.
Second Quarter Financial Highlights  

Total revenues decreased 32.8% to $10,798,076 from $16,079,017 during Q2 2015
Sales and Marketing expenses decreased 48.6% to  $4,056,821 versus $7,890,203 during the comparable period in 2015
General and administrative expenses decreased 36.3% to $3,387,969 from $5,322,385
Total Operating Expenses decreased 43.7 % to $7,444,790 from $13,212,588 during Q2 2015
Net Operating Income Increased from a loss of $1,173,114 in Q2 2015 to a gain of  $338,151
Net Income for the quarter was $189,719 or .01 EPS compared to a loss of $1,446,797 or (.06) EPS during Q2 2015

Second Quarter Highlights 
During the second quarter of 2016, the company experienced exciting updates that included:

Continued Cost Cutting. This includes a reduction

Read more...